Increlex® (mecasermin [rDNA origin]) – ACCREDO SERVICES

Integrating INCRELEX therapy into daily life can be challenging.

Our experienced pharmacy team members counsel parents/patients about adjusting to the therapy regimen.

Accredo Nova Factor reimbursement specialists will bill the patient’s insurance company directly, making the complicated insurance process seamless for both the physician and patient.

Since 1985, Accredo Nova Factor has been dispensing therapies for growth disorders and assisting patients and their physicians who rely on these products. We have the knowledge, dedication to quality and patient focus that you can trust.

If you have any questions about INCRELEX, contact the Growth Disorder Therapies Team.

Increlex is a trademark of Tercica, Inc.